HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $59,210 | +0.2% | 1,550 | -5.4% | 0.00% | – |
Q2 2023 | $59,119 | -91.9% | 1,639 | -91.4% | 0.00% | -100.0% |
Q1 2023 | $731,911 | -62.7% | 19,165 | -44.4% | 0.00% | -75.0% |
Q4 2022 | $1,962,424 | +556.3% | 34,489 | +356.5% | 0.00% | +300.0% |
Q3 2022 | $299,000 | +1561.1% | 7,555 | +1747.2% | 0.00% | – |
Q2 2022 | $18,000 | -95.3% | 409 | -95.2% | 0.00% | -100.0% |
Q2 2021 | $384,000 | +168.5% | 8,446 | +147.0% | 0.00% | 0.0% |
Q1 2021 | $143,000 | +23.3% | 3,420 | +26.0% | 0.00% | – |
Q4 2020 | $116,000 | – | 2,715 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
2Xideas AG | 600,799 | $22,950,522 | 2.54% |
BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |